1st Circ. Questions BioChemics Strategy In SEC Probe Case
By Chris Villani · September 12, 2018, 5:48 PM EDT
The First Circuit prodded BioChemics Inc. on what it felt was an inconsistent argument Wednesday as the pharmaceutical company tried to flip a district court order denying coverage by Axis Reinsurance...
To view the full article, register now.